Diasome Pharmaceuticals Funding: $90M Raised, Series C
Diasome Pharmaceuticals is based in Cleveland, Ohio. It has raised $90M in total funding. Latest round: Series C. Backed by Eli Lilly and Company.
Diasome Pharmaceuticals funding overview
Diasome Pharmaceuticals is based in Cleveland, Ohio. Diasome Pharmaceuticals has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in December 2023. The round record for Diasome Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Eli Lilly and Company.
Diasome Pharmaceuticals at a glance
Total raised
$90M
Latest round
Series C
Latest round date
December 2023
Headquarters
Cleveland, Ohio
Notable investors
Eli Lilly and Company
Frequently asked about Diasome Pharmaceuticals funding
How much has Diasome Pharmaceuticals raised?
Diasome Pharmaceuticals has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Diasome Pharmaceuticals?
Eli Lilly and Company are named among the investors backing Diasome Pharmaceuticals.
What was the latest Diasome Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in December 2023.
Where is Diasome Pharmaceuticals based?
Diasome Pharmaceuticals is based in Cleveland, Ohio.
When did Diasome Pharmaceuticals last raise?
The last disclosed Diasome Pharmaceuticals round closed in December 2023 at Series C.
We update the Diasome Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cleveland and their backers are listed below.
